BioWorld

Aug. 29, 2003

View Archived Issues

Amgen, Genentech Legal War Ends With Payout Settlement

Exploring Brain Neurons In Rats, Fish Rebuts Dogma That Memory Molecules Consolidate Only Once

As IPO Market Improves, Aderis Tries Again, Now Seeking $75M

Holiday notice

Berlex Planning Phase III Study Of Leukine In Crohn's Patients

Other News To Note

Corrections

Myogen Raises $40M Privately, Then Registers For $70M IPO

Falling in step with others in the industry, Myogen Inc. Thursday afternoon said it registered for an initial public offering, estimating it would raise $75 million. (BioWorld Today) Read More

Today's news in brief

BioWorld

BioWorld briefs for July 2, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 30, 2026

Black wavy lines forming an abstract sound wave.png

Deep brain stimulation from the shallows: tomorrow’s BCI technology?

BioWorld

Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...

Handshake, businessmen holding dollar sign, lightbulb

Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal

BioWorld

A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...

AI-generated image for brain organoid neural research

CINP 2026: organoids reveal autism and addiction mechanisms

BioWorld Science

At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...